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ABSTRACT
Introduction: Inadequate stent implantation is
associated with stent thrombosis and restenosis.
StentBoost can enhance stent visualization and
evaluate stent expansion. Currently, there are
limited comparison studies between StentBoost
and intravascular ultrasound (IVUS). We aimed
to test the correlation and agreement between
IVUS and StentBoost measurements.
Methods: From December 2010 to December
2011, 38 patients (54 stents) were analyzed
using IVUS and StentBoost. Minimal stent
diameter and proximal and distal edge stent
diameter were compared between imaging
techniques using Pearson correlation and
Bland–Altman scatter plot.
Results: There was good correlation between
StentBoost and IVUS measurements regarding
minimal stent diameter (p\0.001 in all stent
portions) and an optimal agreement between
IVUS and StentBoost, while lesser agreement
was found between IVUS and quantitative
coronary angiography.
Conclusion: The assessment of stent
implantation using StentBoost showed an
adequate correlation and agreement with IVUS.
This easily applicable angiographic technique
can be used to guide stent implantation.
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Percutaneous coronary intervention (PCI) with
stent implantation constitutes the most
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common form of coronary revascularization,
improving quality of life and even clinical
outcome in certain patient subsets [1, 2].
Advances in stent technology have improved
PCI results; however, acute (stent thrombosis)
and late (in-stent restenosis and thrombosis)
complications still occur [3–5]. Quantitative
angiography (QCA) demonstrated that the
presence of stent underexpansion contributes
to restenosis and stent thrombosis [6].
Furthermore, the use of intracoronary
ultrasound (IVUS) enables a more precise
assessment of stent expansion than QCA and
identifies stent malapposition. Several IVUS
studies have shown that the presence of
insufficient stent expansion and malapposition
remain strong predictors of stent thrombosis [7–
11]; however, this invasive imaging technique is
poorly reimbursed in many regions, increases
procedural complexity and cost and is associated
with significant center-to-center variations [12,
13]. Indeed, the use of IVUS requires technical
expertise to perform and interpret the results.
The StentBoost (Philips Medical Systems,
Eindoven, The Netherlands) is a novel imaging
technique that augments the fluoroscopic
visualization of stents [14]. Through
superimposing motion-corrected acquisition
frames, a superb-quality image of an already
deployed stent can be created.
The aim of this study is to evaluate the
complementary value of using StentBoost to
improve the assessment of stent dimensions in
addition to standard QCA by comparing the
correlation of stent diameter with the gold-
standard measurements by IVUS.
METHODS
This prospective, single-center cohort study
included patients with known obstructive
coronary artery disease undergoing PCI.
Inclusion criteria included patients 18 years old
and a clinical indication for stent implantation.
Exclusion criteria included refusal to participate
in the study, implantation of a stent for in-stent
restenosis, ST-segment elevation myocardial
infarction, emergent procedure, extreme
tortuosity or very small vessels precluding the
use of IVUS. Patients with bifurcations treated
with double stent technique, severely calcified
lesion or lesions that required more than one
stent were also excluded. All procedures followed
were in accordance with the ethical standards of
the responsible committee on human
experimentation (institutional and national)
and with the Helsinki Declaration of 1975, as
revised in 2000 and 2008. Informed consent was
obtained from all patients for being included in
the study.
All patients underwent PCI completely in
accordance with the normal routine from
December 2010 to December 2011. Thirty-eight
patients underwent PCI and were included in the
present analysis. All clinical decisions regarding
the procedure were made by the attending
operator on the basis of his interpretation of
the clinical and procedural data. By study
protocol, StentBoost and IVUS were performed
after stent deployment after results were judged
appropriate by visual assessment of coronary
angiography. Then, IVUS measurements of the
reference vessel and stented segment were made
real time and were available for procedural
decision making. Quantitative analysis of
angiography and quantitative StentBoost were
only performed off-line post-procedure and did
not influence clinical care.
Quantitative Coronary Analysis
Acquisition of all angiographic images was
obtained with a digital flat-panel cardiac imaging
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system (Allura Xper FD 20, Philips Medical Systems,
Bothell, WA, USA). QCA analysis was performed
using a previously validated, commercially
available semi-automated QCA package (Inturis;
Philips Medical Systems, Eindoven, The
Netherlands) that incorporates both edge-
detection and densitometric algorithms. Frames
for QCA analysis were selected from fully opacified
angiograms that provided optimal visualization of
the lesion-treated segment with the least degree of
foreshortening. Calibration was performed with the
use of the contrast-filled guiding catheter as the
reference. Post-PCI, minimal stent diameter and
stent diameter at the proximal and distal edges of
the stent were obtained.
Intravascular Ultrasound
After infusion of 200 lg of intracoronary
nitroglycerin, IVUS was performed using a 2.9
French 40 MHz rotational catheter (AtlantisTM
Pro; Boston Scientific, Natick, MA, USA) with an
automated pullback at 0.5 mm/s. IVUS was
performed after stent implantation or post-
dilation when necessary per study protocol.
Quantitative IVUS analysis was performed
using a commercially available software
package (Galaxy; Boston Scientific, Natick, MA,
USA). Minimal stent area, minimal stent
diameter as well as stent diameter for the
proximal and distal edges were recorded. The
percent area expansion was defined as the
minimum stent area divided by the average of
the proximal and distal reference areas. In
addition, the presence of edge dissections or
hematoma at the stent edges was also recorded.
StentBoost Analysis
StentBoost was performed using a flat-panel
detector that was positioned to minimize stent
foreshortening. With the guiding catheter in the
field and the balloon markers located within the
stented segment, roughly 40 frames of digital
cine (3 s), were acquired without injection of
contrast at 15 frames per second (Fig. 1). The
portion of the frame that includes the stent was
then selected as a region of interest. Automatic
calibration allows measurement of stent
diameters. Similar to QCA, we measured
minimal and maximal stent diameter and two
additional stent diameters (proximal and distal).
The following comparisons were made: minimal
and maximal stent diameter on IVUS to
StentBoost and QCA; and proximal and distal
stent diameter on IVUS to StentBoost and QCA.
Fig. 1 StentBoost enhanced stent image (left). Same image with outlined stent borders (center) StentBoost quantitative
analysis (right) shows a minimal stent diameter of 2.07 mm
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Statistical Analysis
Data are presented as mean values and standard
deviations for continuous variables. Differences
between QCA, IVUS, and StentBoost
measurements were compared using the
Pearson product–moment correlation and
Bland–Altman analysis. All analyses were
performed using SPSS (version 17.0, IBM,
Armonk, New York, USA).
RESULTS
Baseline characteristics are detailed in Table 1. A
total of 54 lesions were stented and comprised
3.8% of the left main, 33.3% of the left anterior
descending, 29.6% of the left circumflex/acute
marginal branch and 33.3% of the right coronary
artery. Of the 54 stents implanted, 42.6% were
Liberte (Boston Scientific, Natick, MA, USA),
16.7% Cypher (Cordis Corporation, Johnson &
Johnson, Warren, NJ, USA) 16.7% Resolute
(Medtronic, Inc., Santa Rosa, CA, USA), 12.0%
Taxus (Boston Scientific, Natick, MA, USA) and
12.0% Presillion (Cordis Corporation, Johnson &
Johnson, Warren, NJ, USA). The average stent
diameter was 3.2 ± 0.5 mm, the stent length was
15.8 ± 12.0 mm, and the stents were deployed at
a mean pressure of 15.2 ± 3.0 atm. From 54
lesions, 57.4% were type A, 20.4% were type B1/
2 and 22.2% were type C. Pre-dilation and post-
dilatation were performed in 50.0 and 33.3% of
the lesions (Fig. 2), respectively.
QCA and StentBoost Measurements
Quantitative angiography measurements were
performed in all 38 patients after placement of
54 stents. The mean percent diameter stenosis by
QCA before intervention was 73 ± 11%. The
mean lesion length was 14 ± 5 mm and vessel
size was 3.25 ± 0.50 mm. After stent delivery
and/or post-dilation, the minimal stent diameter
by QCA was 2.76 ± 0.53 mm (Table 2) and by
StentBoost 2.74 ± 0.49 mm. Stent expansion was
90 ± 8% by QCA and 88 ± 8% by StentBoost.
IVUS Measurements
Intravascular ultrasound measurements were
performed in all 54 stents. The minimal stent
diameter was 3.10 ± 0.51 mm (Table 2). The
percentage of stent expansion was 84 ± 8%.
Proximal and distal reference segment luminal
diameter was 3.60 ± 0.70 and 3.30 ± 0.50 mm,
respectively. Minimal stent area was
7.70 ± 2.90 mm2.
Comparison of Stent Expansion by QCA,
StentBoost and IVUS
Correlation coefficients, r-value and associated
p values for all comparisons are given in Table 3.
For minimal stent diameter assessment, IVUS,
StentBoost and QCA had optimal correlation,
whereas correlations were slightly weaker for
stent diameters at both edges (Table 3).
Table 1 Baseline characteristics
Variable n 5 38




Current smokers 6 (15.8)
Dyslipidemia 32 (84.2)
Prior myocardial infarction 7 (18.4)
Prior coronary bypass grafting 7 (18.4)
Prior percutaneous coronary intervention 24 (63.2)
Continuous variables are presented as mean of six standard
deviations. Dichotomous variables are presented as
numbers (%)
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Correlation between StentBoost and IVUS did not
vary according to vessel size. Bland–Altman
analysis revealed a good agreement between
StentBoost and IVUS for minimal stent diameter
assessment and, in comparison, a lesser agreement
between QCA and IVUS (Figs. 3, 4). Percent stent
expansion by IVUS did not correlate with the one
derived by either QCA or StentBoost.
DISCUSSION
Procedural parameters such as total stent length
and the degree of stent expansion have been
associated with increased risk of restenosis and
thrombosis following PCI [7, 8]. A number of
studies have proposed different IVUS cutoffs (i.e.,
minimal stent cross-sectional area or diameter),
which in turn have predicted repeat
revascularizations after drug-eluting stent DES
and bare-metal stent deployment [4, 15, 16].
Fig. 2 StentBoost enhanced stent images. Above Note
diffuse stent underexpansion (black arrows) after deploy-
ment that was corrected after balloon post-dilatation. Below
Note stent underexpansion focally in the lateral branch
(white arrows) successfully corrected with balloon dilation
Table 2 In-stent measurements by intravascular
ultrasound (IVUS), quantitative angiography (QCA) and
StentBoost
QCA SB IVUS
MSD 2.76 ± 0.53 2.74 ± 0.49 3.10 ± 0.51
MXSD 3.24 ± 0.57 3.18 ± 0.58 3.61 ± 0.59
ASD 3.02 ± 0.53 2.96 ± 0.51 3.33 ± 0.52
Diameter ratioa 0.15 ± 0.07 0.13 ± 0.08 0.16 ± 0.10
ASD average stent diameter, IVUS intravascular
ultrasound, MSD minimal stent diameter, MXSD
maximum stent diameter, QCA quantitative angiography,
SB StentBoost
a MXSD - MSD/MXSD
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Furthermore, the use of IVUS enables recognition
of causes of early stent thrombosis such as the
presence of stent fracture, underexpansion or
inflow/outflow problems [17–19]. Notably,
despite the advantages of the use of IVUS, its
routine use varies considerably between centers.
The use of IVUS adds additional cost and time to
procedures, and requires training of operators
and staff. In addition, although rare,
complications related to IVUS have been
reported [20]. StentBoost is an adjunctive
imaging technique that amplifies fluoroscopic
visualization of stents specifically and is designed
to guide stent deployment. With StentBoost, the
stent can be evaluated in a qualitative fashion
(i.e., evaluation of stent integrity and symmetry)
and in a quantitative objective fashion (i.e., stent
diameter at different segments and in different
projections [21]. In contrast, QCA assessment
quantifies luminal dimension following contrast
coronary injection; however, it does not directly
determine stent dimensions. Thus, QCA and
StentBoost provide additive information and
constitute complementary imaging tools during
PCI. In the present study, the assessment of
minimal stent diameter by StentBoost had a good
correlation and agreement with IVUS. The results
of this study are in line with a previous one that
included 30 patients who underwent IVUS,
StentBoost and QCA [14]. In the
aforementioned study, minimal stent diameter
by IVUS strongly correlated with StentBoost
(r = 0.75, P\0.0001), while a good correlation
was found with QCA (r = 0.65, P\0.0001).
Despite the optimal correlation and agreement
found in our study, the absolute differences in
minimal stent diameter values were not
negligible (0.38 ± 0.06 mm). IVUS allows
circumferential luminal assessment, while
StentBoost is only two dimensional. Possibly,
the use of multiple orthogonal views may
increase StentBoost accuracy, but it may
increase X-ray exposure [22]. Contrary to IVUS,
the use of StentBoost does not significantly
prolong the procedure, since the insertion of an
additional catheter is not needed and imaging
acquisition is rather fast. Although StentBoost
requires additional X-ray exposure, this
increment is minimal with respect to standard
PCI and is not likely to be clinically relevant.
In the present study, the limitations include
the lack of stent area data collection by QCA or
StentBoost and only diameters were compared.
Table 3 Comparison of measurements by intravascular
ultrasound (IVUS), quantitative angiography(QCA) and
StentBoost
(N5 54) R (p value) Absolute
difference
(mm)
MXSD by IVUS and
MXSD by SB
0.70 (\0.001) 0.43 ± 0.45
MXSD by IVUS and
MXSD by QCA
0.73 (\0.001) 0.34 ± 0.35
MSD by IVUS and
MSD by SB
0.68 (\0.001) 0.38 ± 0.06
MSD by IVUS and
MSD by QCA
0.64 (\0.001) 0.44 ± 0.07
ASD by IVUS and
ASD by SB
0.68 (\0.001) 0.36 ± 0.42
ASD by IVUS and
ASD by QCA
0.72 (\0.001) 0.28 ± 0.36
PSD by IVUS and PSD
by SB
0.65 (\0.001) 0.39 ± 0.51
PSD by IVUS and PSD
by QCA
0.70 (\0.001) 0.29 ± 0.50
DSD by IVUS and
DSD by SB
0.65 (\0.001) 0.39 ± 0.50
DSD by IVUS and
DSD by QCA
0.65 (\0.001) 0.36 ± 0.49
ASD average stent diameter, DSD stent diameter, IVUS
intravascular ultrasound, MSD minimal stent diameter,
MXSD maximum stent diameter, PSD proximal stent
diameter, QCA quantitative angiography, SB StentBoost
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Recent innovation in StentBoost technique
allows concomitant coronary injection while
acquiring StentBoost images. This combination
of luminogram and StentBoost or so called
StentBoost subtraction is capable of identifying
discrepancies in QCA and StentBoost
dimensions, because of either stent
malapposition or plaque prolapse. Figure 5
demonstrates the value of contrasted
StentBoost showing an underdeployed stent,
which was unnoticed by traditional
angiography.
In conclusion, this single-center cohort
study evaluated the role of StentBoost during
stent implantation assessment. Minimal stent
diameter measured using StentBoost, IVUS and
QCA demonstrated good correlation and
agreement, with the highest agreement
Fig. 3 Scatter plots comparing minimal stent diameter: left StentBoost and intravascular ultrasound (IVUS) measurements,
right quantitative angiography (QCA)and IVUS
Fig. 4 Bland–Altman analysis demonstrates optimal agreement in minimal stent diameter assessment between StentBoost
and IVUS and suboptimal agreement between QCA and IVUS
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between StentBoost and IVUS. Further research
is warranted to define the role of StentBoost in
patients undergoing more complex PCI. Future
advances in three-dimensional image could
improve StentBoost diagnostic accuracy,
especially in cases with complex coronary
anatomy.
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